advanced search

News & Events

Home News & Events Content

Gynecologic oncology team from Department of Radiation Oncology obtains achievements in both basic and clinical research

Updated: May 26, 2020
From: Department of Radiation Oncology
Edited by: Liu Huiting

Recently, American Society for Therapeutic Radiology and Oncology (ASTRO) announced the selected abstracts for the 2020 annual meeting. Five original articles from the gynecologic oncology team of Department of Radiation Oncology of the First Affiliated Hospital of Xi 'an Jiaotong University (XJTU) were selected. The article entitled ‘Application of concurrent chemoradiotherapy for elderly patients with cervical cancer’, authored by Shi Fanet al., was selected as oral presentation at the conference. The research results, such as assessment of vaginal injury during brachytherapy for cervical cancer and application of AI technology in the diagnosis and treatment of cervical cancer, were included for poster exchange.

ASTRO annual meeting is a global gathering in the field of radiation oncology. The presentations in the annual meeting represent the highest scientific research level and development direction in the field of radiation oncology. This year, more than 3,300 articles have been submitted by the radiation oncology teams around the globe.

Over the recent two decades, the specialty of gynecologic oncology of Department of Radiation Oncology has carried out and improved a series of clinical and applied basic researches regarding precision treatment, improving clinical efficacy of radiotherapy for cervical cancer and mitigating radiation-induced injury. Among them, ‘Cinical study of intraoperative radiotherapy for gynecologic oncology’ launched by the team led by Professor Liu Zi was published in Clinical Radiation Oncology, a prestigious American journal. Relevant research outcomes were recognized as ‘Xi 'an Experience’ and discussed along with the experience of Mayo Clinic and Stanford University,etc. It was also an essential part of the first prize of Scientific and Technological Progress Project in Shaanxi Province. The team pioneered by Professor Chen Hongwei completed a large-scale case-control study of concurrent chemoradiotherapy and hyperthermia for advanced cervical cancer after more than 10-year arduous efforts. Relevant results were published in International Journal of Radiation Oncology Biology Physics, a top-notched journal in the field of radiation oncology. Multiple ongoing studies related to in vitro precise irradiation and brachytherapy have maintained the gynecologic oncology specialty with leading or advanced technological levels at home and abroad.

Previous:Department of Medical Imaging successfully holds International Seminar of "India & China Together Fight COVID-19"
Next:Our hospital reports one COVID-19 patient positive for SARS-CoV-2 in top-notched ophthalmology journal

Copyright (c) 2011, First Affiliated Hospital of Xi 'an Jiaotong University Shaanxi ICP for 12009712-3